Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kazuyoshi, Kirimura"'
Autor:
Shinji, Takai 1, Denan, Jin 1, Kazuyoshi, Kirimura 2, Junko, Ikeda 2, Masato, Sakaguchi 1, Kimiye, Baba 3, Tadashi, Fujita 2, Mizuo, Miyazaki 1
Publikováno v:
In Japanese Journal of Pharmacology 1999 80(1):89-92
Autor:
Mizuo Miyazaki, Katsuhiro Yoshikawa, Mika Nakabayashi, Shinji Takai, Kanta Kishi, Yoshiki Mino, Denan Jin, Kazuyoshi Kirimura, Michiko Muramatsu
Publikováno v:
Hypertension Research. 28:457-464
Vascular smooth muscle cells in spontaneously hypertensive rats (SHR) express angiotensin II-forming chymase (rat vascular chymase [RVCH]), which may contribute to blood pressure regulation. In this study, we studied whether chymase-dependent angiote
Autor:
Yoshiki Mino, Katsuhiro Yoshikawa, Kazuyoshi Kirimura, Denan Jin, Mizuo Miyazaki, Shinji Takai, Michiko Muramatsu
Publikováno v:
Hypertension Research. 28:593-600
Although the lipophilicities of the various angiotensin II receptor blockers (ARBs) are very different, the relationship between lipophilicity and the protective effect against vascular remodeling is unclear. In this study, we compared the protective
Autor:
Michiko Muramatsu, Denan Jin, Mizuo Miyazaki, Masato Sakaguchi, Kazuyoshi Kirimura, Hiroshi Sakonjo, Kenji Ishii, Shinji Takai
Publikováno v:
Hypertension Research. 27:517-522
Angiotensin II receptor blockers could prevent the development of atherosclerosis beyond reducing blood pressure in monkeys fed a high-cholesterol diet. However, it has been unclear whether hypotensive effects improve atherosclerosis in primates. We
Publikováno v:
Clinica Chimica Acta. 305:191-195
We studied the angiotensin II-forming pathways in extracts from human and rat vascular tissues. In the extract from human artery, angiotensin I mainly converted to two products, angiotensin-(1-9) and angiotensin II, while in the extract from rat arte
Autor:
Mizuo Miyazaki, Denan Jin, Masato Sakaguchi, Atsushi Yuda, Shinji Takai, Kazuyoshi Kirimura, Masayoshi Nishimoto
Publikováno v:
European Journal of Pharmacology. 411:301-304
Cilostazol prevents neointimal formation, but its mechanism has remained unclear. We investigated whether intimal formation in dog grafted veins is suppressed by cilostazol, and studied the effect of cilostazol on angiotensin II-forming enzymes. The
Autor:
Tadashi Fujita, Junko Ikeda, Denan Jin, Masato Sakaguchi, Mizuo Miyazaki, Kimiye Baba, Shinji Takai, Kazuyoshi Kirimura
Publikováno v:
Japanese Journal of Pharmacology. 80:89-92
We investigated whether a lipoxygenase inhibitor, panaxynol, affected the vascular contraction induced by angiotensin (Ang) II and the mean arterial pressure in spontaneously hypertensive rats (SHR). Panaxynol suppressed dose-dependently the contract
Autor:
Mizuo Miyazaki, Shinji Takai, Hiroshi Sakonjo, Maki Kimura, Kazuyoshi Kirimura, Denan Jin, Kazuhiko Tanaka
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 30(12)
The angiotensin receptor blocker (ARB) telmisartan is a partial agonist of peroxisome proliferator-activated receptor gamma (PPARgamma). Typical PPARgamma agonists suppress the gene expression of angiotensin-converting enzyme (ACE) in vascular tissue
Autor:
Hiroshi Sakonjo, Mizuo Miyazaki, Michiko Muramatsu, Kazuyoshi Kirimura, Shinji Takai, Denan Jin
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 46(5)
Aldosterone may be involved in the pathogenesis of atherosclerosis. We investigated the effect of eplerenone, a selective mineralocorticoid receptor blocker, on atherosclerosis in monkeys fed a high-cholesterol diet. Monkeys fed a high-cholesterol di
Publikováno v:
Japanese journal of pharmacology. 86(1)
We investigated the effects of a novel chymase inhibitor, BCEAB (4-[1-[[bis-(4-methyl-phenyl)-methyl]-carbamoyl]-3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid). The IC50 value of BCEAB for purified human chymase was 5.4 nM, whereas BCEAB